Thursday, July 18, 2019

Expected advantage of general screening for hepatitis C in donated blood for prevention of hepatocellular carcinoma: a report from endemic setting

Yasri S. Expected advantage of general screening for hepatitis C in donated blood for prevention of hepatocellular carcinoma: a report from endemic setting. Adv Trop Med Pub Health Int. 2019; 9: 1 - 4.


ABSTRACT

Hepatocellular carcinoma is an important cancer seen worldwide. The high prevalence is seen in tropical Asia and is related to several underlying factors including to hepatitis virus infection. the hepatitis C virus is a carcinogenic pathogen that can induced hepatocellular carcinogenesis. This virus is transmittable via blood contact and the blood transfusion is an important cause of disease transmission. The screening for hepatitis C virus in donated blood is the proposed method for prevention of disease transmission. In this article, the authors summarize and present the expected advantage of general screening for hepatitis C in donated blood for prevention of hepatocellular carcinoma. Although the cost per utility of the screening is high it is still less expensive than the cost for management of hepatitis C related hepatocellular case.

Key words:  prevention, blood transfusion, hepatitis C, donation

No comments:

Post a Comment